Doripenem Injection 500 mg – Advanced Sterile Antibiotic Solution for London, UK
Manufactured with precision. Developed for Modern Healthcare.
Ernest Oncology proudly presents Doripenem Injection 500 mg, a sterile carbapenem antibiotic manufactured using advanced pharmaceutical technology in India. Every vial is produced inside WHO-GMP-certified manufacturing facilities that follow stringent aseptic procedures to ensure outstanding sterility, formulation stability, pharmaceutical purity, and consistent batch quality.
The formulation is intended for intravenous (IV) administration under the supervision of qualified healthcare professionals.
London Pharmaceutical Market Information
London is home to one of Europe's most sophisticated healthcare systems, supported by internationally recognized hospitals, specialist treatment centers, and medical research institutions. Healthcare providers continue to prioritize sterile injectable medicines manufactured according to globally accepted pharmaceutical standards that emphasize quality, safety, and therapeutic reliability.
India remains one of the world's leading pharmaceutical manufacturing countries, recognized for producing high-quality injectable medicines through advanced technology and internationally compliant production systems.
Product Overview
| Product Details | Information |
|---|---|
| Product Name | Doripenem Injection |
| Strength | 500 mg |
| Generic Name | Doripenem |
| Dosage Form | Sterile Powder for Injection |
| Route of Administration | Intravenous (IV) |
| Therapeutic Category | Carbapenem Antibiotic |
| Packaging | Sterile Glass Vial |
| Country of Origin | India |
Key Features
- Doripenem sterile injectable formulation
- Carbapenem-class antibiotic
- Sterile powder for IV administration
- WHO-GMP certified manufacturing
- Pharmaceutical-grade formulation
- High product stability
- Batch-tested quality assurance
- Advanced aseptic production
- Export-quality packaging
- Manufactured under international quality standards
Product Description
Doripenem Injection 500 mg contains Doripenem, a broad-spectrum carbapenem antibiotic formulated as a sterile powder for intravenous administration. Manufactured using validated pharmaceutical processes, the formulation is developed to maintain sterility, product integrity, and formulation consistency from production through packaging.
Each batch undergoes extensive quality evaluation before release to ensure compliance with internationally accepted pharmaceutical manufacturing standards.
Mechanism of Action
Doripenem belongs to the carbapenem family of antibiotics.
It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). This process weakens susceptible bacteria, leading to bacterial destruction and helping control bacterial infections.
Recommended Dosage
The dosage should always be determined by a qualified healthcare professional.
Treatment recommendations are based on:
- Type of bacterial infection
- Severity of illness
- Patient age
- Body weight
- Kidney function
- Overall clinical condition
Administration should always be carried out by trained healthcare professionals.
Possible Side Effects
Some individuals may experience temporary side effects during treatment.
Possible reactions include:
- Injection site discomfort
- Nausea
- Vomiting
- Diarrhea
- Headache
- Skin rash
- Fever
- Dizziness
- Allergic reactions
- Temporary liver enzyme changes
Seek medical advice if symptoms become severe or persistent.
Safety Information
- Prescription-only medicine.
- Intended for intravenous administration only.
- Inform your healthcare provider about previous allergies to antibiotics.
- Complete the prescribed treatment course.
- Do not use expired medicine.
- Store safely away from children.
- Follow all physician instructions carefully.
Storage Information
- Store below 25°C
- Protect from moisture
- Keep away from direct sunlight
- Store in original packaging
- Do not freeze
- Use before the expiry date
Quality Assurance
Every doripenem injection manufactured by Ernest Oncology undergoes comprehensive pharmaceutical quality evaluation before release.
Our Quality Standards
- WHO-GMP certified manufacturing facilities
- Sterility validation
- Batch-wise laboratory testing
- Raw material quality verification
- Stability monitoring
- Packaging inspection
- Complete product traceability
- Continuous quality improvement
Documentation
The following documents are generally available:
- Commercial Invoice
- Packing List
- Certificate of Analysis (COA)
- Certificate of Origin (COO)
- Product Specification Sheet
- Certificate of Pharmaceutical Product (CPP)* (where applicable)
- Batch Manufacturing Record* (where applicable)
- Airway Bill / Bill of Lading
Partner with Ernest Oncology
At Ernest Oncology, we believe every pharmaceutical product should reflect scientific precision, uncompromising quality, and responsible manufacturing. Our commitment to advanced technology, strict quality standards, and continuous innovation enables us to develop reliable medicines that contribute to better healthcare and improved patient outcomes worldwide.
Why Choose Indian Pharmaceutical Manufacturing
Indian pharmaceutical companies continue to earn global confidence by combining innovation with internationally accepted manufacturing standards.
Manufacturing Advantages
- WHO-GMP certified production facilities
- Modern sterile injectable manufacturing
- International pharmaceutical quality standards
- High-quality active pharmaceutical ingredients
- Reliable batch-to-batch consistency
- Advanced quality assurance laboratories
- Export-grade packaging systems
- Scientific manufacturing expertise
- Continuous pharmaceutical innovation
- Globally respected manufacturing reputation
